Bruckner Oncology Center

Bruckner Oncology Center is a specialized medical practice and clinical research facility located in the Bronx, New York, led by Dr. Howard W. Bruckner. The center is distinguished by its focus on "low dose multi-drug therapy," an innovative approach that uses combinations of approved chemotherapeutic agents at lower doses to enhance efficacy and reduce toxicity in patients with resistant or advanced cancers. In addition to providing personalized oncology care, the center serves as a site for clinical trials, participating in the development of novel treatments such as gene therapies. Bruckner Oncology specializes in treating difficult-to-manage malignancies, including pancreatic, ovarian, and gastrointestinal cancers, often for patients who have failed standard-of-care treatments. The facility integrates laboratory research with clinical practice to develop predictive blood tests and personalized treatment algorithms. Its mission is to provide hope and improved survival outcomes for patients considered ineligible for traditional high-dose protocols.